NPWT, or vacuum-assisted wound closure therapy, uses sub-atmospheric pressure to treat acute and persistent wounds. NPWT devices are available in various shapes and sizes to accommodate a patient's body type and the extent of the damage that needs to be repaired. These tools, which consist of a vacuum pump, drainage tubing, and dressing set, improve patient well-being by hastening the healing of wounds, reducing the frequency of dressing changes, and providing a valuable substitute for treating closed surgical incision lines. As the prevalence of chronic diseases like diabetes mellitus and obesity rises along with the global elderly population, the market for negative pressure wound therapy devices is predicted to grow.
The global elderly population has significantly expanded in recent years. They are more likely to develop chronic diseases, including arthritis, cancer, type 2 diabetes, obesity, and cardiovascular conditions. Furthermore, older adults are more likely to get certain illnesses like stomach cancer. Therefore, NPWT devices are required to treat ulcers brought on by chronic medical conditions like diabetes. Similar to how incision-based surgical therapy is necessary for treating chronic disorders, including cancer, arthritis, and cardiovascular disease. NPWT devices are required since these incisions have a high surgical site infection risk. Thus, a major factor propelling the market for negative pressure wound therapy devices is the significant rise in the senior population globally.
The market for wound care has excellent growth potential because it is a developing therapeutic area. The demand for negative pressure wound therapy devices is driven by the significant unmet need in this clinical area caused by the rise in acute and chronic wounds worldwide. More clinical practices being taught in medical schools, increased care coordination between therapies and places of care, and enhanced decision tools and standards for NPWT devices are all projected to open up various future market opportunities.
North America is the most significant revenue contributor and is anticipated to expand at a CAGR of 4.50% over the projection period. The United States, Canada, and Mexico are three important North American countries analyzed in the paper. In 2019, the mature market of the United States brought in the most money for North America. According to the American Medical Association and JAMA network, 4.5 million Americans experienced chronic wounds in 2018. The cost of treating chronic wounds is rapidly rising due to rising healthcare costs, an aging population in the United States, and an increase in diabetes and obesity worldwide.
Europe is anticipated to grow at a CAGR of 5.90% during the forecast period. The European NPWT device market analysis considers Germany, France, the UK, Italy, Spain, and the rest of Europe. Europe has proven to be the second-largest market for NPWT devices. The UK and Spain are expected to grow strongly during the projection period, while developed European nations like Germany, France, and Italy are predicted to experience steady growth.
The global negative pressure wound therapy devices market's major key players are ConvaTec Inc., Cardinal Health, Inc., Smith and Nephew plc, 3M, and Mölnlycke Health Care AB.